Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set

Biofilm-associated infections impose a substantial burden on clinical practice, yet in vitro data generated to guide therapeutic development frequently fail to predict in vivo outcomes. This review advances a problem-solving argument: although host immunity, pharmacokinetics, tissue penetration, and infection-site biology also shape clinical outcomes, a major and modifiable contributor to this predictive failure is the systematic simplification of the measured object away from the resistance mechanisms operating within the infection microenvironment. Across five axes of divergence (surface, medium conditioning, operational steps, timing, and readout with controls), we identify gaps and failure modes that weaken the link between bench data and clinical outcome. Recent evidence shows that crystal violet and XTT staining report different biological parameters and agree with each other, and with viable counts, only under defined conditions; standardized parameters for minimum biofilm eradication concentration testing remain absent, and that growth mode, aggregation propensity, and growth rate, which vary between strains, strongly influence biofilm formation and resistance in ways conventional assays poorly capture. We propose a research agenda centered on physiologically conditioned platforms, multi-endpoint readouts, confounding controls, maturity-indexed endpoints, and growth-mode heterogeneity, offering a proposed, as yet unvalidated, minimum reporting framework intended to make assay conditions auditable and results comparable across studies, as a prerequisite for, rather than a demonstration of, clinical predictive validity.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-11-18
DOI
https://doi.org/10.3390/microorganisms14112675
Primary Topic
Bacterial biofilms and quorum sensing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set

Salma Elnour Rahma Mohamed, Sarah Ali, Mohamed Ibrahim Saeed
Microorganisms
Bacterial biofilms and quorum sensing
article

Why In Vitro Biofilm Susceptibility Data Fail to Predict In Vivo Outcomes: Five Axes of Divergence and a Proposed Minimum Reporting Set

Salma Elnour Rahma Mohamed, Sarah Ali, Mohamed Ibrahim Saeed
article en

Abstract

Biofilm-associated infections impose a substantial burden on clinical practice, yet in vitro data generated to guide therapeutic development frequently fail to predict in vivo outcomes. This review advances a problem-solving argument: although host immunity, pharmacokinetics, tissue penetration, and infection-site biology also shape clinical outcomes, a major and modifiable contributor to this predictive failure is the systematic simplification of the measured object away from the resistance mechanisms operating within the infection microenvironment. Across five axes of divergence (surface, medium conditioning, operational steps, timing, and readout with controls), we identify gaps and failure modes that weaken the link between bench data and clinical outcome. Recent evidence shows that crystal violet and XTT staining report different biological parameters and agree with each other, and with viable counts, only under defined conditions; standardized parameters for minimum biofilm eradication concentration testing remain absent, and that growth mode, aggregation propensity, and growth rate, which vary between strains, strongly influence biofilm formation and resistance in ways conventional assays poorly capture. We propose a research agenda centered on physiologically conditioned platforms, multi-endpoint readouts, confounding controls, maturity-indexed endpoints, and growth-mode heterogeneity, offering a proposed, as yet unvalidated, minimum reporting framework intended to make assay conditions auditable and results comparable across studies, as a prerequisite for, rather than a demonstration of, clinical predictive validity.

MicroorganismsVol. 14(11)
Gulf Medical University (AE)
Good health and well-being
Bacterial biofilms and quorum sensing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon